Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Bak

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 13, 2020
Association of preceding psychosis risk states and non-psychotic mental disorders with incidence of clinical psychosis in the general population: a prospective study in the NEMESIS-2 cohortSinan Guloksuz, Lotta-Katrin Pries, Margreet Ten Have, et al.
JAMA Psychiatry|August 18, 2020
Association of Recent Stressful Life Events With Mental and Physical Health in the Context of Genomic and Exposomic Liability for SchizophreniaLotta-Katrin Pries, Jim van Os, Margreet Ten Have, et al.
Social Psychiatry and Psychiatric Epidemiology|August 1, 2022
Age- and sex-specific associations between risk scores for schizophrenia and self-reported health in the general populationVincent Paquin, Lotta-Katrin Pries, Margreet Ten Have, et al.
BMC Psychiatry|January 6, 2021
Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trialNini de Boer, Sinan Guloksuz, Caroline van Baal, et al.
The International Journal of Risk & Safety in Medicine|November 1, 2021
Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoinDavid Healy, Audrey Bahrick, Maarten Bak, et al.
Trials|February 9, 2020
To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trialMarieke J H Begemann, Ilse A Thompson, Wim Veling, et al.
Psychological Medicine|October 19, 2021
Longitudinal clinical and functional outcome in distinct cognitive subgroups of first-episode psychosis: a cluster analysisPriscilla P Oomen, Marieke J H Begemann, Bodyl A Brand, et al.
Psychological Medicine|October 19, 2020
Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathwayJim van Os, Lotta-Katrin Pries, Margreet Ten Have, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 13, 2020
Association of preceding psychosis risk states and non-psychotic mental disorders with incidence of clinical psychosis in the general population: a prospective study in the NEMESIS-2 cohortSinan Guloksuz, Lotta-Katrin Pries, Margreet Ten Have, et al.
JAMA Psychiatry|August 18, 2020
Association of Recent Stressful Life Events With Mental and Physical Health in the Context of Genomic and Exposomic Liability for SchizophreniaLotta-Katrin Pries, Jim van Os, Margreet Ten Have, et al.
Social Psychiatry and Psychiatric Epidemiology|August 1, 2022
Age- and sex-specific associations between risk scores for schizophrenia and self-reported health in the general populationVincent Paquin, Lotta-Katrin Pries, Margreet Ten Have, et al.
BMC Psychiatry|January 6, 2021
Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trialNini de Boer, Sinan Guloksuz, Caroline van Baal, et al.
The International Journal of Risk & Safety in Medicine|November 1, 2021
Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoinDavid Healy, Audrey Bahrick, Maarten Bak, et al.
Trials|February 9, 2020
To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trialMarieke J H Begemann, Ilse A Thompson, Wim Veling, et al.
Psychological Medicine|October 19, 2021
Longitudinal clinical and functional outcome in distinct cognitive subgroups of first-episode psychosis: a cluster analysisPriscilla P Oomen, Marieke J H Begemann, Bodyl A Brand, et al.
Psychological Medicine|October 19, 2020
Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathwayJim van Os, Lotta-Katrin Pries, Margreet Ten Have, et al.
Pageof 6